Gapping up
In reaction to earnings/guidance:
- PEP +2.8%, ETWO +0.7%
Other news:
- CANG +23.5% (approves special dividend of $0.50 per ordinary share or $1 per ADS)
- LOCO +12.7% (declares $1.50/sh special div; also authorizes new $20 mln share repurchase program)
- KNBE +11.4% (KnowBe4 is close to a deal to be acquired by Vista Equity Partners according to WSJ)
- AUTL +9.1% (announces that Moderna has exercised its option to license Autolus' proprietary binders against an undisclosed immuno-oncology target for the development and commercialization of mRNA therapeutics)
- GATO +8.5% (increases production guidance and lowers cost guidance for 2022)
- RCKT +4.5% (Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy)
- SGMO +4.2% (Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Nine Patients)
- AB +4.1% (reports September AUM)
- ESTE +4% (purchases 3 mln shares from Warburg Pincus)
- GRIN +3.5% (Announces Agreement With Taylor Maritime Investments Limited)
- ANGI +3.4% (reports Sept performance metrics)
- RCMT +3.4% (acquires TalentHerder)
- AMRN +3.3% (issues statement in response to Sarissa)
- MRNA +3% (Moderna & Merck (MRK) announce exercise of option by Merck for joint development and commercialization of investigational personalized cancer vaccine) ATAI +3% (positive initial results for phase 1 trial of KUR-101 an oral formulation of mitragynine for OUD)
- UVE +2.3% (provides update on Hurricane Ian impact)
- BGNE +2.3% (announces positive topline results from final progression-free survival analysis of BRUKINSA (zanubrutinib) Compared to IMBRUVICA (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia Trial)
- GRNA +2% (announces realignment to focus on near-term value drivers)
- MSM +1.7% (increases dividend)
- IAC +1.3% (reports Sept performance metrics)
- AWK +1.2% (to purchase Butler Area Sewer Authority for $231.5 mln)
- BEP +1.1% (CCJ and BEP form partnership to acquire Westinghouse Electric)
- TRIP +1.1% (CFO to retire names new CFO)
- GE +1% (files Form 10 with SEC for planned spin-off of GE HealthCare)
- UEC +1% (to acquire Roughrider from Rio Tinto (RIO) for $150 mln)
Analyst comments:
- NOV +3.2% (upgraded to Buy from Neutral at Citigroup)
- AIG +1.6% (upgraded to Buy from Hold at Jefferies)